iRadimed Corporation (IRMD)
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IRMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.04B
- P/E (TTM)
- 43.33
- Forward P/E
- 33.25
- EPS (TTM)
- $1.87
- Dividend yield
- 0.99% ($0.80)
- Ex-dividend date
- Nov 13, 2026
- 52-week range
- 76.35 – 107.90
- Day range
- 80.61 – 82.11
- Volume / Avg
- 101.30K / 120.89K
- Beta
- —
- Shares outstanding
- 12.79M
52-week range
IRMD stock today
iRadimed (IRMD) closed at $81.02 on Nov 20, down 0.30% (-$0.24), versus the S&P 500's 3.70% decline. At this level, IRMD sits near the bottom of its 52-week range of $76.35 to $107.90: 24.9% below the high, set on Feb 10, 2026 and 6.1% above the low. IRMD is down 16.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.5%.
iRadimed trades at 43.3x its trailing twelve-month earnings per share of $1.87. Its forward P/E of 33.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. iRadimed pays an annual dividend of $0.80 per share, a 0.99% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About iRadimed
Company profileIRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Roger E. Susi
- Headquarters
- Orlando, FL
- Employees
- 166
- IPO year
- 2014
- Website
- iradimed.com
Financial highlights
Full financialsIn fiscal 2025, iRadimed generated $83.8 million in revenue, up 14.4% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $22.5 million (+16.9% year over year), for a net margin of 26.8% versus a median of 24.1% in the prior 5 years. Gross margin was 76.7% (down from 76.9%) and operating margin 31.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $83.81M | $73.24M | $65.56M | $53.30M | $41.81M |
| Growth | +14.43% | +11.71% | +23.00% | +27.48% | +31.83% |
| Net income | $22.48M | $19.23M | $17.19M | $12.83M | $9.33M |
| EPS (diluted) | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 |
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$118.00+45.64%
- Strong buy 0
- Buy 2
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 30, 2026
- EPS actual vs est.
- $0.51 vs $0.52
- Surprise
- -1.92%
Dividends
Dividend history- Annual dividend
- $0.80
- Dividend yield
- 0.99%
- Last payment
- $0.20
- Ex-dividend date
- Nov 13, 2026
- Pay date
- Nov 27, 2026
IRMD news
All IRMD news- Iradimed (IRMD) Q3 2026 Earnings Call TranscriptNasdaq
- Iradimed anticipates $25M-$26.5M Q4 revenue as 3870 pump output targets 50%+ sequential growthSeeking Alpha
- iRadimed Non-GAAP EPS of $0.55 in-line, revenue of $24.2M beats by $0.77MSeeking Alpha
- IRADIMED CORPORATION Reports Third Quarter 2026 Financial ResultsGlobeNewswire
- iRadimed Q3 2026 Earnings PreviewSeeking Alpha
- IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026GlobeNewswire
iRadimed peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IARTIntegra LifeSciences Holdings Corporation | 13.25 | -2.21% | $1.03B | vs IRMD |
| ATECAlphatec Holdings Inc. | 6.68 | -3.19% | $1.02B | vs IRMD |
| SGPSpyGlass Pharma Inc. | 30.43 | -1.14% | $1.02B | vs IRMD |
| SIBNSI-BONE Inc. | 23.73 | -0.08% | $1.07B | vs IRMD |
| DRTSAlpha Tau Medical Ltd. | 11.76 | +3.93% | $1.09B | vs IRMD |
| AORTArtivion Inc. | 18.16 | -2.00% | $886.02M | vs IRMD |
| TNDMTandem Diabetes Care Inc. | 17.46 | +3.93% | $1.22B | vs IRMD |
| KIDSOrthoPediatrics Corp. | 31.74 | -2.37% | $828.75M | vs IRMD |
Indexes, lists and sector
iRadimed stock FAQ
What is iRadimed's stock price today?
IRMD last traded at $81.02 as of Nov 20, 4:00 PM EST, down 0.30% on the day. Prices are delayed at least 15 minutes.
Does iRadimed pay a dividend?
Yes. iRadimed pays $0.80 per share annually, a 0.99% yield. The most recent dividend of $0.20 had an ex-dividend date of Nov 13, 2026.
What is IRMD's P/E ratio?
IRMD trades at a trailing P/E ratio of 43.33 and a forward P/E of 33.25.
Who is iRadimed's CEO?
Mr. Roger E. Susi is the chief executive officer of iRadimed Corporation, which has about 166 employees.
What is the IRMD 52-week high?
The 52-week high for IRMD is $107.90 and the 52-week low is $76.35. The stock is currently 24.9% below its high.